Relationship between elevated liver enzyme with iron overload and viral hepatitis in thalassemia major patients in Northern Iran

Saudi Medical Journal

Volumn 29, Issue 11, 2008, Pages 1611-1615

  Ameli, Mitra ^a   Besharati, Sepiedeh ^b   Nemati, Kourosh ^b   Zamani, Farhad ^c  

^a ISLAMIC AZAD UNIVERSITY   (Iran)

^b GUILAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; FERRITIN; HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY; IRON; LIVER ENZYME; TRANSFERRIN;

ADOLESCENT; ADULT; AGE; ARTICLE; BLOOD TRANSFUSION; CHILD; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HOSPITAL DEPARTMENT; HUMAN; IRAN; IRON OVERLOAD; MAJOR CLINICAL STUDY; MALE; THALASSEMIA MAJOR; BETA THALASSEMIA; BLOOD; ENZYMOLOGY; LIVER; MIDDLE AGED; PRESCHOOL CHILD;

ADOLESCENT; ADULT; ALANINE TRANSAMINASE; BETA-THALASSEMIA; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; HEPATITIS C; HUMANS; IRAN; IRON OVERLOAD; LIVER; MIDDLE AGED;

EID: 58949086119     PISSN: 03795284     EISSN: 16583175     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Higgs DR, Thein SL, Woods WG. The molecular pathology of the thalassaemias. In: Weatherall DJ, Clegg B, editors. The thalassaemia syndromes. 4th ed. Oxford (UK): Blackwell Science; 2001. p. 133-191.
2. Cunningham MJ, Macklin EA, Neufeld EJ, Cohen AR; Thalassemia Clinical Research Network. Complications of beta-thalassemia major in North America. Blood 2004; 104: 34-39.
3. Rund D, Rachmilewitz E. Beta-thalassemia. N Engl J Med 2005; 353: 1135-1146.
4. Kontoghiorghes GJ. Advances in oral iron chelation in man. Int J Hematol 1992; 55: 27-38.
5. Kontoghiorghes GJ, Pattichi K, Hadjigavriel M, Kolnagou A. Transfusional iron overload and chelation therapy with deferoxamine and deferipone (L1). Transfus Sci 2000; 23: 211-223.
6. Olivieri NF. The beta-thalassemias. N Engl J Med 1999; 341: 99-109.
7. Hoffbrand AV, Cohen A, Hershko C. Role of deferiprone in chelation therapy for transfusional iron overload. Blood 2003; 102: 17-24.
8. Borgna-Pignatti C, Rugolotto S, De Stefano P, Zhao H, Cappellini MD, Del Vecchio GC, et al. Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine. Haematologica 2004; 89: 1187-1193.
9. Bradai M, Pissard S, Abad MT, Dechartres A, Ribeil JA, Landais P, et al. Decreased transfusion needs associated with hydroxyurea therapy in Algerian patients with thalassemia major or intermedia. Transfusion 2007; 47: 1830-1836.
10. Borgna-Pignatti C. Modern treatment of thalassaemia intermedia. Br J Haematol 2007; 138: 291-304.
11. Rezvan H, Abolghassemi H, Kafiabad SA. Transfusion-transmitted infections among multitransfused patients in Iran: A review. Transfus Med 2007; 17: 425-433.
12. Wonke B, Hoffbrand AV, Brown D, Dusheiko G. Antibody to hepatitis C virus in multiply transfused patients with thalassaemia major. J Clin Pathol 1990; 43: 638-640.
13. Cohen AR, Galanello R, Pennell DJ, Cunningham MJ, Vichinsky E. Thalassemia. In: American Society of Hematology, editor. Hematology. 2004. Boston: American Society of Hematology. Educational Program Book; 2004.
14. Silva IS, Perez RM, Oliveira PV, Cantagalo MI, Dantas E, Sisti C, et al. Iron overload in patients with chronic hepatitis C virus infection: clinical and histological study. J Gastroenterol Hepatol 2005; 20: 243-248.
15. Prati D, Maggioni M, Milani S, Cerino M, Cianciulli P, Coggi G, et al. Clinical and histological characterization of liver disease in patients with transfusion-dependent beta-thalassemia. A multicenter study of 117 cases. Haematologica 2004; 89: 1179-1186.
16. Ruhl CE, Everhart JE. Relation of elevated serum alanine aminotransferase activity with iron and antioxidant levels in the United States. Gastroenterology 2003; 124: 1821-1829.
17. Worwood M, Cragg SJ, Jacobs A, McLaren C, Ricketts C, Economidou J. Binding of serum ferritin to concanavalin A: Patients with homozygous beta thalassaemia and transfusional iron overload. Br J Haematol 1980; 46: 409-416.
18. Maier KP. [The patient with slightly increased liver function tests]. Praxis (Bern 1994) 2005; 94: 139-143. German
19. Wu SF, Peng CT, Wu KH, Tsai CH. Liver fibrosis and iron levels during long-term deferiprone treatment of thalassemia major patients. Hemoglobin 2006; 30: 215-218.
20. Chang CJ, Ko YC, Liu HW. Serum alanine aminotransferase levels in relation to hepatitis B and C virus infections among drug abusers in an area hyperendemic for hepatitis B. Dig Dis Sci 2000; 45: 1949-1952.
21. Wang CS, Wang ST, Chou P. Using the prevalence of an elevated serum alanine aminotransferase level for identifying communities with a high prevalence of hepatitis C virus infection. Arch Intern Med 2001; 161: 392-394.
22. Wang CS, Wang ST, Chang TT, Yao WJ, Chou P. Smoking and alanine aminotransferase levels in hepatitis C virus infection: Implications for prevention of hepatitis C virus progression. Arch Intern Med 2002; 162: 811-815.
23. Chakravarti A, Verma V. Distribution of hepatitis C virus genotypes in beta-thalassaemic patients from Northern India. Transfus Med 2006; 16: 433-438.
24. Wanachiwanawin W, Luengrojanakul P, Sirangkapracha P, Leowattana W, Fucharoen S. Prevalence and clinical significance of hepatitis C virus infection in Thai patients with thalassemia. Int J Hematol 2003; 78: 374-378.
25. Ocak S, Kaya H, Cetin M, Gali E, Ozturk M. Seroprevalence of hepatitis B and hepatitis C in patients with thalassemia and sickle cell anemia in a long-term follow-up. Arch Med Res 2006; 37: 895-898.
26. Gattoni A, Parlato A, Vangieri B, Bresciani M, Derna R, Baldassarre R. Role of hemochromatosis genes in chronic hepatitis C. Clin Ter 2006; 1571: 61-68.
27. Jaiswal SP, Chitnis DS, Jain AK, Inamdar S, Porwal A, Jain SC. Prevalence of hepatitis viruses among multi-transfused homogenous thalassaemia patients. Hepatol Res 2001; 19: 247-253.
28. Mirmomem S, Alavian SM, Hajarizadeh B, Kafaee J, Yektaparast B, Zahedi MJ, et al. Epidemiology of hepatitis B, hepatitis C, and human immunodeficiency virus infecions in patients with beta-thalassemia in Iran: A multicenter study. Arch Iran Med 2006; 9: 319-323.